Drug intelligence / Profile preview

Biqi Capsule (Tianjin Darentang Jingwanhong Pharmaceutical)

Development stage
Unknown
Lead developer
Tianjin Darentang Jingwanhong Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Biqi Capsule (痹祺胶囊) is a traditional Chinese medicine (TCM) compound preparation used primarily for the treatment of rheumatoid arthritis and related musculoskeletal disorders. Its formula is based on classical TCM principles, combining ten herbal ingredients including processed Strychnos nux-vomica (马钱子粉), Pheretima aspergillum (地龙), Codonopsis pilosula (党参), Poria cocos (茯苓), Atractylodes macrocephala (白术), Ligusticum wallichii (川芎), Salvia miltiorrhiza (丹参), Panax notoginseng (三七), Achyranthes bidentata (牛膝), and Glycyrrhiza uralensis (甘草)[1][3][6][9]. The capsule is indicated for replenishing qi and blood, dispelling wind-dampness, promoting blood circulation, and relieving pain. It is clinically used for symptoms such as muscle and joint soreness, swelling or deformity of joints, muscle atrophy, fatigue due to qi-blood deficiency, as well as rheumatic diseases like rheumatoid arthritis, lumbar muscle strain, soft tissue injuries[1][4][5][6]. Mechanistically, its anti-inflammatory effects are attributed to active components such as cryptotanshinone from Salvia miltiorrhiza and brucine/strychnine from Strychnos nux-vomica; these compounds have been shown to inhibit nitric oxide production and reduce inflammatory cytokines in preclinical studies[6]. The product has been widely used in China since 1991 with clinical evidence supporting its efficacy in rheumatology[9].

Brand names
Biqi Capsule 痹祺胶囊
Other names
痹祺胶囊
02

Targets

NOS1 (nNOS)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on Biqi Capsule (Tianjin Darentang Jingwanhong Pharmaceutical).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biqi Capsule (Tianjin Darentang Jingwanhong Pharmaceutical).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call